Baxter International BAX Advanced Surgery — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's advanced surgery — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's advanced surgery — net sales?
- Baxter International (BAX) reported advanced surgery — net sales of $304M in Q1 2026.
- How has Baxter International's advanced surgery — net sales changed year-over-year?
- Baxter International's advanced surgery — net sales increased by 13.4% year-over-year, from $268M to $304M.
- What is the long-term trend for Baxter International's advanced surgery — net sales?
- Over 4 years (2021 to 2025), Baxter International's advanced surgery — net sales has grown at a 5.2% compound annual growth rate (CAGR), from $977M to $1.2B.
- What does advanced surgery — net sales mean?
- The total revenue earned from selling advanced surgical products and equipment.
- How do you interpret advanced surgery — net sales?
- An increase indicates growing market adoption and successful commercialization of surgical technologies, while a decrease may signal competitive pressure or reduced procedure volumes.
- How does advanced surgery — net sales compare across companies?
- Comparable to surgical product revenue segments at major medical device manufacturers like Medtronic or Stryker.